Skip to content
10-K

Annual Report

Oyster Point Pharma, Inc.

0001720725-22-000028

← back to feed
Filed
Feb 24, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 16, 2022 26.63M sh
Shares Diluted FY 2021 · Dec 31, 2021 26.04M sh
Shares Diluted FY 2021 · Dec 31, 2020 24.13M sh
Capex FY 2021 · Dec 31, 2021 $1.49M
Capex FY 2021 · Dec 31, 2020 $700K
Operating Cash Flow FY 2021 · Dec 31, 2021 −$89.37M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$58.4M
Long Term Debt FY 2021 · Dec 31, 2021 $89.82M
Long Term Debt FY 2021 · Dec 31, 2020 $0
Cash And Equivalents FY 2021 · Dec 31, 2021 $193.37M
Cash And Equivalents FY 2021 · Dec 31, 2020 $192.59M
Cash And Equivalents FY 2021 · Dec 31, 2019 $139.15M
Stockholders Equity FY 2021 · Dec 31, 2021 $99.54M
Stockholders Equity FY 2021 · Dec 31, 2020 $186.66M
Stockholders Equity FY 2021 · Dec 31, 2019 $137.3M
Current Liabilities FY 2021 · Dec 31, 2021 $28.8M
Current Liabilities FY 2021 · Dec 31, 2020 $10.98M
Total Liabilities FY 2021 · Dec 31, 2021 $123.08M
Total Liabilities FY 2021 · Dec 31, 2020 $11.25M
Current Assets FY 2021 · Dec 31, 2021 $215.25M
Current Assets FY 2021 · Dec 31, 2020 $196.37M
Total Assets FY 2021 · Dec 31, 2021 $222.62M
Total Assets FY 2021 · Dec 31, 2020 $197.91M
Eps Diluted FY 2021 · Dec 31, 2021 −$3.87
Eps Diluted FY 2021 · Dec 31, 2020 −$2.92
Eps Basic FY 2021 · Dec 31, 2021 −$3.87
Eps Basic FY 2021 · Dec 31, 2020 −$2.92
Sga Expense FY 2021 · Dec 31, 2021 $40.81M
Sga Expense restated FY 2021 · Dec 31, 2020 $21.31M
Rd Expense FY 2021 · Dec 31, 2021 $24.23M
Rd Expense FY 2021 · Dec 31, 2020 $39.81M
Net Income FY 2021 · Dec 31, 2021 −$100.66M
Net Income FY 2021 · Dec 31, 2020 −$70.52M
Operating Income FY 2021 · Dec 31, 2021 −$96.66M
Operating Income FY 2021 · Dec 31, 2020 −$70.99M
Cost Of Revenue FY 2021 · Dec 31, 2021 $1.53M
Cost Of Revenue FY 2021 · Dec 31, 2020 $0
Revenue FY 2021 · Dec 31, 2021 $24.54M
Revenue FY 2021 · Dec 31, 2020 $0